- Global Pharma News & Resources

Impact of Covid19 on Cardiac Biomarkers Market, Future Growth 2020-2027 | Market to Reach USD 14.29 Billion with CAGR 10.4%

: New York, United States, 28-July-2020, (Via WiredRelease), (Reports and Data) – According to the current analysis of Reports and Data, the global Cardiac Biomarkers market was valued at USD 6.44 Billion in 2018 and is expected to reach USD 14.29 Billion by year 2026, at a CAGR of 10.4%.

According to the Centre for Disease Control and Prevention (CDC), for around 610,000 people die of heart disease in United States every year, that’s 1 in every 4 deaths and more than half of the deaths due to heart disease were in men. Cardiac biomarkers are protein-based observable materials discharged into blood when the heart’s muscles are wounded which can be used as risk stratification for numerous cardiovascular diseases (CVDs) that includes Acute Myocardial Infarction (AMI), Ischemia, Congestive Heart Failure (CHF), Acute Coronary Syndrome (ACS) and others related with insufficient blood flow to heart.

The high occurrence rates of CVDs worldwide and the growing demand for POC cardiac testing kits are expected to fuel the market growth. Certain manufacturing, limited specificity and pharmacological issues and regulatory hurdles are hindering the growth of the market.

Get Sample Copy with TOC of the Report to understand the structure of the complete report @

The COVID-19 impact:
Covid-19’s spread has affected manufacturing and construction activities worldwide. Logistic limitations and reconsiderations of the raw material requirements are becoming a problem for producers. The producers have relied on derived demand as an intermediate commodity to rationalize production. The pandemic’s economic impact on companies and financial markets is also not favorable. Stock market volatility and decreasing global growth are anticipated, which will affect the market.  The market has experienced a downturn over the weeks, which may continue over the next few months. The Asia Pacific is the most affected region by this pandemic, with China at the center of the outbreak. Most initiatives in multiple countries have changed to a temporary halt. Development, as well as supply, is put on hold, creating losses for suppliers, dealers and customers alike.

Key participants include

Abbott Laboratories, Alere Inc. and Roche Diagnostics Corporation        .

Get Discount on the report @

For the purpose of this report, Reports and Data have segmented into the global Cardiac Biomarkers market on the basis of type, propellants, application, and region:

Product Type (Revenue, USD Million; 2016–2026)

Brain Natriuretic Peptide (BNPs) or NT-proBNPIschemia Modified Albumin (IMA)MyoglobinTroponins (T and I)Myocardial muscle Creatine Kinase (CK-MB)Others

Location of Testing (Revenue, USD Million; 2016–2026)

Laboratory TestingPoint of Care Testing

Application (Revenue, USD Million; 2016–2026)

Myocardial InfarctionCongestive Heart FailureAcute Coronary SyndromeAtherosclerosisOthers

End User (Revenue, USD Million; 2016–2026)

Diagnostic LaboratoriesHospitals and Clinics

Regional Outlook (Revenue, USD Million; 2017-2027)

North America





Asia Pacific





Latin America


To identify the key trends in the industry, click on the link below:

Key aspects of the Cardiac Biomarkers Market Report:

The report comprises of Cardiac Biomarkers market overview, market share, demand and supply ratio, supply chain analysis, and import/export details.

The report explores different strategies and procedures undertaken by key market players that assist in making profitable decisions.

The report covers all the crucial information about the products and services of major competitors.

About Us:
Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and development analysis, and demand estimation among others, we can help you invest your funds in the most beneficial areas for research and development.

Contact Us:
John Watson
Head of Business Development
Reports and Data | Web:
Direct Line: +1-212-710-1370

This content has been published by MARKETYSERS GLOBAL CONSULTING LLP company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 28-Jul-2020